Project: Comprehensive in vitro immune response testing

COMPIT aims to position itself in the (bio)pharmaceutical market with the development of a unique in vitro platform for the testing and prediction of the full human immune response to drugs. The system merges cutting-edge immune response testing, 3D tissue models and ultrasensitive analytical assays based on the contemporary theory of the ‘Danger Model’. COMPIT is outperforming current immune response testing and is complementary to current information obtained from preclinical studies.

Acronym	COMPIT (Reference Number: 10456)
Duration	01/08/2016 - 01/08/2018
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 5

Project partner

Number	Name	Role	Country
24136	ImmunoSYS Ltd	Partner	United Kingdom
24137	Abundnz BV	Coordinator	Netherlands